Pathology EMQ template.

Name: Kate West

Candidate number:

Theme: Immune therapies

 

OPTION LIST

 

A	Azathioprine	I	Interferon-γ
B	Cyclophosphamide	J	Prednisolone
C	Cyclosporin	K	Toclizumab
D	Denosumab	L	Ustekinumab
E	Etanercept	M
F	Infliximab	N
G	Interferon-α	O
H	Interferon-β	P

 

 

For each scenario below, choose the most appropriate answer from the list above. Each option may be used once, more than once or not at all.

 

1. Licensed to treat chronic granulomatous disease

 

 

2. This agent inhibits DNA replication by alkylating guanine residues

 

 

3. An anti-proliferative agent that is particularly toxic to patients with specific TPMT polymorphisms

 

 

4. Used to treat osteoporosis by targeting RANK ligand

 

 

5. This agent inhibits IL-6 responses and is used in the treatment of rheumatoid arthritis and Castleman’s disease

 

 

 

ANSWERS

1. I

2. B

3. A

4. D

5. K